TKTL Antibodies

Santa Cruz Biotechnology features a diverse variety of TKTL monoclonal antibodies for the study of transketolase-like protein (TKTL). TKTL monoclonal antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Transketolase-like protein plays a crucial role in the pentose phosphate pathway, which is essential for cellular metabolism and the generation of nucleotides and amino acids. TKTL has been identified as a key factor in metabolic processes, making it an important target for understanding various diseases, including cancer and metabolic disorders. The regulation of TKTL expression can significantly impact cellular growth and proliferation, highlighting its relevance in both basic and applied research. Researchers have found that TKTL activity levels correlate with specific disease states, making it a promising area for therapeutic development. Understanding TKTL function has opened new avenues for investigating metabolic pathways and their influence on disease progression. TKTL research continues to reveal new insights into cellular metabolism and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for TKTL support researchers worldwide in advancing scientific understanding of metabolic processes and disease pathways.